Hsu, C., Lui, K., Chi, L., Kuo, Y., Chao, Y., Yeh, C., . . . Li, H. (2018). Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma. BMC.
Chicago Style (17th ed.) CitationHsu, Cheng-Lung, et al. Integrated Genomic Analyses in PDX Model Reveal a Cyclin-dependent Kinase Inhibitor Palbociclib as a Novel Candidate Drug for Nasopharyngeal Carcinoma. BMC, 2018.
MLA (8th ed.) CitationHsu, Cheng-Lung, et al. Integrated Genomic Analyses in PDX Model Reveal a Cyclin-dependent Kinase Inhibitor Palbociclib as a Novel Candidate Drug for Nasopharyngeal Carcinoma. BMC, 2018.
Warning: These citations may not always be 100% accurate.